During the past decade, Orange County Research Center conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 41 clinical trials were completed, i.e. on average, 46.1% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 19 clinical trials were completed. i.e. 39.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orange County Research Center" #1 sponsor was "Pfizer" with 18 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Société des Produits Nestlé (SPN)" with 9 trials sponsored, "Oramed, Ltd." with 8 trials sponsored and "Amgen" with 8 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange County Research Center" #1 collaborator was "Integrium" with 18 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Orange County Research Center" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Orange County Research Center" are "Diabetes Mellitus, Type 2" (11 trials), "Type 2 Diabetes Mellitus" (10 trials), "Heart Failure" (9 trials), "Hepatic Impairment" (9 trials) and "Hypertension" (9 trials). Many other conditions were trialed in "Orange County Research Center" in a lesser frequency.

Most popular intervention types in "Orange County Research Center" are "Drug" (117 trials), "Other" (25 trials), "Biological" (12 trials), "Dietary Supplement" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "placebo" (6 trials), "Dapagliflozin" (5 trials), "Cenderitide" (3 trials) and "Metformin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Orange County Research Center" are 136 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Orange County Research Center". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Orange County Research Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Orange County Research Center, 49 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".